|
- Medications that are immunosuppressive or immunomodulatory
Transplant-related immunosuppressive drugs These types of medications are commonly taken after transplant to prevent rejection of the transplant They are also used in other auto-immune conditions
- On the Horizon: Immuno-Oncology (I-O) Combinations
Stimulatory factors shown in green promote immunity, Where will Improvements come from? A dramatic and unprecedented increase in clinical cancer immunotherapy combination studies (across
- Management of Immune-Related Adverse Events in Patients . . .
PURPOSE To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy
- Immune-Related Response Criteria: Variations in I-O Response . . .
Checkpoint inhibitors: tumors escape detection by the immune system through expression of “checkpoint” proteins on their cell surface CTLA-4 and PD-1 receptors are examples of “checkpoint” receptors; targeted inhibition towards these receptors enhances T cell response towards the tumor
- A patient’s guide to Immuno-Oncolo - medschool. lsuhsc. edu
mmuno- oncology, or s metimes known as cancer immunotherapy ‘Immuno’ in immuno- cology refers to your immune system Immuno-oncology uses drugs known as immunotherapies that target your body� s immune system to help fight cancer This guide will he p you understand cancer immun
- Understanding the science behind Immuno-Oncology
Using the body’s natural immune response to fight cancer Bristol Myers Squibb: At the forefront of Immuno-Oncology research
- IMMUNO-ONCOLOGY - Bristol Myers Squibb
Immuno-oncology, or cancer immunotherapy, uses the body’s immune system to fight cancer The immune system plays a key role in stopping cancer cells from growing and spreading T cells, which are part of the immune system, are important for fighting cancer T cells from attacking
|
|
|